Literature DB >> 12411763

Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype.

T Gabryelewicz1, D Religa, M Styczynska, B Peplonska, A Pfeffer, B Wasiak, E Luczywek, M Golebiowski, W Androsiuk, K Czyzewski, I Przekop, M Barcikowska.   

Abstract

The aim of this study was to define the co-occurrence of behavioural symptoms and Alzheimer's disease (AD) in relation to apolipoprotein E (APOE) genotype. Probable AD patients from the Alzheimer's Day Clinic (n = 139) were assessed with the 'Behavioural Pathology in Alzheimer's Disease' rating scale, and their APOE genotype was determined. This study demonstrated no relationship between presence of the APOE epsilon4 allele and any of the behavioural symptoms assessed, including delusions, hallucinations, depression, activity disturbances, aggressiveness and anxiety. Activity disturbances, delusions, hallucinations and aggressiveness paralleled the severity of AD, increasing in frequency with the severity of the dementia. The prevalence of delusions, hallucinations, aggressiveness and depression were found to be associated with lower levels of education. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411763     DOI: 10.1159/000066020

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  11 in total

Review 1.  Pharmacogenomics and therapeutic prospects in dementia.

Authors:  Ramón Cacabelos
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03       Impact factor: 5.270

2.  Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.

Authors:  Winnie Qian; Corinne E Fischer; Tom A Schweizer; David G Munoz
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

3.  The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease.

Authors:  A L Pritchard; J Harris; C W Pritchard; J Coates; S Haque; R Holder; P Bentham; C L Lendon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-15       Impact factor: 10.154

4.  Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease.

Authors:  Liana G Apostolova; Li Jie Di; Erin L Duffy; Jenny Brook; David Elashoff; Chi-Hong Tseng; Lynn Fairbanks; Jeffrey L Cummings
Journal:  Dement Geriatr Cogn Disord       Date:  2014-01-25       Impact factor: 2.959

Review 5.  Genetics of psychosis in Alzheimer's disease: a review.

Authors:  Mary Ann DeMichele-Sweet; Robert A Sweet
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.

Authors:  Katherine A Treiber; Constantine G Lyketsos; Chris Corcoran; Martin Steinberg; Maria Norton; Robert C Green; Peter Rabins; David M Stein; Kathleen A Welsh-Bohmer; John C S Breitner; JoAnn T Tschanz
Journal:  Int Psychogeriatr       Date:  2008-02-21       Impact factor: 3.878

Review 7.  Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease.

Authors:  Ramón Cacabelos
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

8.  ApoE alleles, depression and positive affect in multiple sclerosis.

Authors:  L J Julian; L Vella; D Frankel; S L Minden; J R Oksenberg; D C Mohr
Journal:  Mult Scler       Date:  2009-03       Impact factor: 6.312

9.  APOE genotype predicts depression in women with Alzheimer's disease: a retrospective study.

Authors:  Lisa Delano-Wood; Wes S Houston; Jennifer A Emond; Natalie L Marchant; David P Salmon; Dilip V Jeste; Leon J Thal; Mark W Bondi
Journal:  Int J Geriatr Psychiatry       Date:  2008-06       Impact factor: 3.485

10.  Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene.

Authors:  Francesco Panza; Davide Seripa; Grazia D'Onofrio; Vincenza Frisardi; Vincenzo Solfrizzi; Patrizia Mecocci; Alberto Pilotto
Journal:  Int J Alzheimers Dis       Date:  2011-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.